OFF-LABEL USE OF PD-1 BLOCKADE WITH OR WITHOUT BEVACIZUMAB CONFERS ONLY LIMITED CLINICAL BENEFIT IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMASylvia Eisele, Lais Cabrera,David Hastie,David Reardon,Mikael Rinne,Lakshmi Nayak,Eudocia Lee,Patrick WenNeuro-oncology(2017)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要